Pr
Prevail (Lilly)
New York NYFounded 2017100 employees
Private CapbiotechAcquiredNeurology
Platform: AAV Neurodegeneration
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niracagene | PRE-3798 | Preclinical | 2 | BCL-2 | Parkinson'sHeart Failure | ||
| PRE-6102 | PRE-6102 | Preclinical | 2 | HER2 | CSU |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)